Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Pituitary Neoplasms 1Haloperidol 1Growth Hormone-Secreting Pituitary Adenoma 1Carcinoma, Basal Cell 1Breast Neoplasms 1Acromegaly 1

Interventions

Tomography, Optical Coherence 3Biopsy 3methyl 5-aminolevulinate 2daromun 2Mohs Surgery 2Imiquimod 2Aminolevulinic Acid 2Watchful Waiting 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Solutions 1Patient Reported Outcome Measures 1Nivolumab 1Niacinamide 1Methylation 1Itraconazole 1Immunologic Factors 1Hydrogen Peroxide 1Glatiramer Acetate 1Fluorouracil 1Electroporation 1Dermoscopy 1Curettage 1Cryotherapy 1Coat Protein Complex I 1Cautery 1Capecitabine 1Calcium Chloride 1BF-200 ALA 15-aminolevulinic acid hexyl ester 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Carcinoma, Basal Cell × Solutions × Clear all
NCT04929535 2022-08-30

Hydrogen Peroxide Trial to Investigate the Efficacy of 30%H2O2 as a Topical Application Before Definitive Treatment

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

Phase 2 Unknown
51 enrolled
Dermatologic

Carcinoma, Basal Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡